Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02321423 · ClinicalTrials.gov registry record
International Pachyonychia Congenita Research Registry
A clinical trial of Pachyonychia Congenita, sponsored by Pachyonychia Congenita Project.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT02321423: Recruiting study of Pachyonychia Congenita, sponsored by Pachyonychia Congenita Project.
NCT02321423 is a study of Pachyonychia Congenita that is actively recruiting participants, run by Pachyonychia Congenita Project. The registered enrollment target is 2,000 participants, above the 42-participant average among 4 other Pachyonychia Congenita trials with a reported enrollment target (4662% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02321423, a study of Pachyonychia Congenita, is actively recruiting participants, sponsored by Pachyonychia Congenita Project.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
International Pachyonychia Congenita Research Registry (IPCRR) is a patient registry for those suffering from Pachyonychia Congenita (PC). PC is an ultra-rare extremely painful skin disorder that causes painful blisters and callus on feet and sometimes hands, thickened nails, cysts and other features. The IPCRR consists of a questionnaire, patient photos, optional physician notes from telephone consultation to validate questionnaire and free genetic testing.
Conditions Studied
Study Locations (1)
Utah
- Pachyonychia Congenita Project - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2004-04 |
| Est. Completion | 2030-12 |
What NCT02321423 shows while recruiting
NCT02321423 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 42-participant average among 4 other Pachyonychia Congenita trials with a reported enrollment target (4662% higher).
The record links to 1 condition, with Pachyonychia Congenita appearing as the primary indexed condition, and to 0 interventions.
NCT02321423 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT02321423 about?
NCT02321423 is a clinical study titled "International Pachyonychia Congenita Research Registry". International Pachyonychia Congenita Research Registry (IPCRR) is a patient registry for those suffering from Pachyonychia Congenita (PC). PC is an ultra-rare extremely painful skin disorder that causes painful blisters and callus on feet and sometimes hands, thickened nails, cysts and other feature...
What is the current status of trial NCT02321423?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2004-04. Estimated completion is 2030-12.
What conditions does trial NCT02321423 study?
This clinical trial studies the following conditions: Pachyonychia Congenita.
Who is sponsoring clinical trial NCT02321423?
This trial is sponsored by Pachyonychia Congenita Project, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02321423 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pachyonychia Congenita
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita
RECRUITING · Phase 3
-
Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
COMPLETED · Phase 1
-
VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita
COMPLETED · Phase 3
-
Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia